Mohammed Azharuddin

2.5k total citations
9 papers, 166 citations indexed

About

Mohammed Azharuddin is a scholar working on Endocrinology, Diabetes and Metabolism, Pharmacology and Physiology. According to data from OpenAlex, Mohammed Azharuddin has authored 9 papers receiving a total of 166 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Endocrinology, Diabetes and Metabolism, 2 papers in Pharmacology and 2 papers in Physiology. Recurrent topics in Mohammed Azharuddin's work include Vitamin C and Antioxidants Research (2 papers), Diabetes Treatment and Management (2 papers) and Meta-analysis and systematic reviews (1 paper). Mohammed Azharuddin is often cited by papers focused on Vitamin C and Antioxidants Research (2 papers), Diabetes Treatment and Management (2 papers) and Meta-analysis and systematic reviews (1 paper). Mohammed Azharuddin collaborates with scholars based in United Kingdom, India and Canada. Mohammed Azharuddin's co-authors include D S O’Reilly, Dinesh Talwar, Rajesh V. Thakker, Paul Newey, Stephen J. Cleland, Donald C. McMillan, Christian B. Willberg, Russell Drummond, Cathy Williamson and P. Anton van der Merwe and has published in prestigious journals such as New England Journal of Medicine, Diabetes and Clinical Chemistry.

In The Last Decade

Mohammed Azharuddin

8 papers receiving 162 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mohammed Azharuddin United Kingdom 5 58 47 38 20 16 9 166
Linda E Kelemen Canada 4 32 0.6× 31 0.7× 29 0.8× 23 1.1× 18 1.1× 4 184
Mona Nourbakhsh Iran 8 31 0.5× 42 0.9× 49 1.3× 48 2.4× 15 0.9× 22 179
Alberto B. Alonso United States 10 99 1.7× 49 1.0× 78 2.1× 25 1.3× 20 1.3× 14 306
Sandra Hebshi United States 11 75 1.3× 104 2.2× 39 1.0× 17 0.8× 13 0.8× 14 354
Geoff Beckett United Kingdom 10 193 3.3× 36 0.8× 71 1.9× 20 1.0× 26 1.6× 16 318
Vasudha Ahuja United States 9 47 0.8× 53 1.1× 32 0.8× 27 1.4× 26 1.6× 19 240
Keita Chikamoto Japan 5 24 0.4× 69 1.5× 54 1.4× 37 1.9× 18 1.1× 8 162
Manuel Castro-Cabezas Spain 6 42 0.7× 36 0.8× 30 0.8× 44 2.2× 25 1.6× 8 156
M Assayag France 7 87 1.5× 20 0.4× 26 0.7× 42 2.1× 50 3.1× 10 240
Maria J. Gómez-Luna Spain 7 50 0.9× 69 1.5× 45 1.2× 73 3.6× 25 1.6× 8 218

Countries citing papers authored by Mohammed Azharuddin

Since Specialization
Citations

This map shows the geographic impact of Mohammed Azharuddin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammed Azharuddin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammed Azharuddin more than expected).

Fields of papers citing papers by Mohammed Azharuddin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohammed Azharuddin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammed Azharuddin. The network helps show where Mohammed Azharuddin may publish in the future.

Co-authorship network of co-authors of Mohammed Azharuddin

This figure shows the co-authorship network connecting the top 25 collaborators of Mohammed Azharuddin. A scholar is included among the top collaborators of Mohammed Azharuddin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohammed Azharuddin. Mohammed Azharuddin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
McInnes, Natalia, Stephanie Hall, Heather Lochnan, et al.. (2023). Diabetes remission and relapse following an intensive metabolic intervention combining insulin glargine/lixisenatide, metformin and lifestyle approaches: Results of a randomised controlled trial. Diabetes Obesity and Metabolism. 25(11). 3347–3355. 8 indexed citations
3.
Cartwright, Douglas, et al.. (2020). 1 Hyperglycaemia in T1DM and pancreatitis related diabetes. Postgraduate Medical Journal. 96(1132). 119–119. 1 indexed citations
4.
Azharuddin, Mohammed, et al.. (2015). EVALUATION OF ANTI-THYROID ACTIVITY OF FICUS RACEMOSA LINN BARK IN MALE RATS. 7(3). 118–122. 7 indexed citations
5.
Azharuddin, Mohammed, et al.. (2015). GASTROPROTECTIVE POTENTIAL OF LASIA SPINOSA IN ALBINO RATS. 7(3). 254–257. 1 indexed citations
6.
Azharuddin, Mohammed, et al.. (2014). ANTICATARACT POTENTIAL OF BARLERIA PRIONITIS: IN VIVO STUDY. 7(2). 100–105. 4 indexed citations
7.
Newey, Paul, Caroline M. Gorvin, Stephen J. Cleland, et al.. (2013). Mutant Prolactin Receptor and Familial Hyperprolactinemia. New England Journal of Medicine. 369(21). 2012–2020. 77 indexed citations
8.
Azharuddin, Mohammed, D S O’Reilly, Andrew Gray, & Dinesh Talwar. (2007). HPLC Method for Plasma Vitamin K1: Effect of Plasma Triglyceride and Acute-Phase Response on Circulating Concentrations. Clinical Chemistry. 53(9). 1706–1713. 29 indexed citations
9.
Talwar, Dinesh, et al.. (2005). Biological Variation of Vitamins in Blood of Healthy Individuals. Clinical Chemistry. 51(11). 2145–2150. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026